Emerging Infectious Diseases

San Francisco declares local public health emergency over monkeypox

San Francisco declared monkeypox a local public health emergency last week as New York state designated the disease an imminent…

2 years ago

FDA approves Bavarian Nordic manufacturing capabilities, frees up 786,000 more monkeypox vaccine doses

Monkeypox vaccine production is about to experience a significant surge following the U.S. Food and Drug Administration’s (FDA) approval this…

2 years ago

Congressional letters to White House mount over monkeypox response

More than 100 members of Congress, backed by more than 100 organizations, sent a letter to the Biden administration this…

2 years ago

Senators push for federal acknowledgement of and work to change inequities in vaccine access amid monkeypox outbreak

As an international monkeypox outbreak continues to grow in scope, U.S. Sens. Dianne Feinstein (D-CA), Jeff Merkley (D-OR), and 20…

2 years ago

HHS orders 2.5 million more JYNNEOS monkeypox vaccines, makes thousands more available

As concerns about the monkeypox outbreak worldwide continued to grow, the U.S. Department of Health and Human Services (HHS) responded…

2 years ago

Aegis Sciences begins testing for monkeypox in boost to U.S. testing capacity

Beginning last week, Aegis Sciences began testing for monkeypox at its laboratories in Nashville, Tenn., adding potential capacity for up…

2 years ago

Pandemic prevention in focus with passage of National Defense Authorization Act

A major provision of the recently passed National Defense Authorization Act (NDAA, or H.R. 7900) – which advanced from the…

2 years ago

FDA authorizes Novavax COVID-19 Vaccine, Adjuvanted for emergency use on severe adult cases

Bolstering the number of options for use against SARS-CoV-2, the United States Food and Drug Administration (FDA) issued an emergency…

2 years ago

COVID-19 pandemic caused setbacks in fight against antimicrobial resistant infections throughout United States

While the general focus has been on the immediate effects of the COVID-19 pandemic, the outbreak also reversed years of…

2 years ago

NIAID launches clinical phase 1 trial of mRNA Nipah virus vaccine

Nipah virus became the newest target of the National Institute of Allergy and Infectious Diseases (NIAID) this week, with the…

2 years ago

This website uses cookies.